Table 3.

Associations between the biomarkers and clinicopathological parameters in the colorectal polyps' group

Colorectal polyps	CEA	CA19-9	FIT	Septin9	SDC2	BCAT1	Composite score (P)
Number
Single (N = 45)
Mean ± SD	2.6 ± 2.0	13.3 ± 10.4	1.1 ± 0.3	44.3 ± 1.5	44.8 ± 1.1	44.9 ± 0.8	0.3 ± 0.7
Positive (%)	5 (11.1)	3 (6.7)	3 (6.7)	1 (2.2)	2 (4.4)	1 (2.2)	1 (2.2)
Multiple (N = 85)
Mean ± SD	5.7 ± 22.7	10.5 ± 8.0	1.2 ± 0.4*	44.0 ± 2.1	44.6 ± 1.5	44.7 ± 1.1	0.4 ± 0.9
Positive (%)	17 (20)	4 (4.7)	17 (20)	6 (7.1)	10 (11.8)	7 (8.2)	3 (3.5)
Size
≤1 cm (N = 93)
Mean ± SD	5.4 ± 21.7	11.3 ± 9.1	1.1 ± 0.3	44.1 ± 2.0	44.7 ± 1.4	44.8 ± 0.8	0.4 ± 0.9
Positive (%)	18 (19.4)	6 (6.5)	10 (10.8)	4 (4.3)	7 (7.5)	5 (5.4)	3 (3.2)
>1 cm (N = 37)
Mean ± SD	2.8 ± 1.7	11.9 ± 8.7	1.3 ± 0.5*	44.3 ± 1.7	44.6 ± 1.2	44.7 ± 1.32	0.3 ± 0.8
Positive (%)	4 (10.8)	1 (2.7)	10 (27)*	3 (8.1)	5 (13.5)	3 (8.1)	1 (2.7)
Advanced adenoma
No (N = 83)
Mean ± SD	3.0 ± 2.5	11.8 ± 10.0	1.1 ± 0.5	44.1 ± 2.1	44.6 ± 1.5	44.8 ± 0.9	0.36 ± 0.9
Positive (%)	13 (15.7)	6 (7.2)	7 (8.4)	4 (4.8)	7 (8.4)	5 (6.0)	3 (3.6)
Yes (N = 47)
Mean ± SD	7.6 ± 30.4	10.9 ± 7.0	1.3 ± 0.3*	44.3 ± 1.6	44.7 ± 1.0	44.7 ± 1.2	0.3 ± 0.7
Positive (%)	9 (19.1)	1 (2.1)	13 (27.7)*	3 (6.4)	5 (10.6)	3 (6.4)	1 (2.1)

CA19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; FIT, fecal immunochemical test for hemoglobin.

*P < 0.05.